InterVenn Revenue and Competitors
Estimated Revenue & Valuation
- InterVenn's estimated annual revenue is currently $33.7M per year.
- InterVenn's estimated revenue per employee is $193,750
- InterVenn's total funding is $278.1M.
Employee Data
- InterVenn has 174 Employees.
- InterVenn grew their employee count by -8% last year.
InterVenn's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Operations, Quality & Regulatory | Reveal Email/Phone |
2 | VP, Translational Science and Develpoment | Reveal Email/Phone |
3 | SVP, Clinical Operations & Patient Affairs | Reveal Email/Phone |
4 | Chief Data Officer | Reveal Email/Phone |
5 | Director Accounting | Reveal Email/Phone |
6 | Director, Clinical Operations & Patient Affairs | Reveal Email/Phone |
7 | Senior Manager, Biomarker Validation | Reveal Email/Phone |
8 | Staff Scientist | Reveal Email/Phone |
9 | General Manager - Philippines | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
InterVenn Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is InterVenn?
InterVenn combines next generation epiproteomics, instrumentation and deep learning to augment cancer diagnosis, biomarker and target discovery.
keywords:N/A
$278.1M
Total Funding
174
Number of Employees
$33.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
InterVenn News
InterVenn is a clinical technology company leveraging AI-powered software to unlock the value of glycoproteomics for the development of...
InterVenn is pioneering a new AI-powered platform to decode and unlock the potential of the glycoproteome for the first time in history.
InterVenn Biosciences today raised $34 million to further develop its platform for precision medicine. The New York-based startup says the funds will be used to accelerate its go-to-market, expansion, and ongoing product R&D efforts. Mass spectrometry, a technique that measures the mass-to-char ...
InterVenn BioSciences, a Redwood City, Calif.-based life sciences and technology company developing an AI-driven mass spectrometry platform, raised $9.4m in funding. The round was led by biotech investor Genoa Ventures, with participation from True Ventures, Amplify Partners, Boost VC, and Prad ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $76.7M | 176 | -32% | $420.4M |
#2 | $59.4M | 177 | -2% | N/A |
#3 | $23.4M | 178 | 11% | $319.7M |
#4 | $27.6M | 178 | 6% | N/A |
#5 | $37.2M | 192 | -7% | $92.1M |